315 related articles for article (PubMed ID: 25254920)
1. Plan A: postabortion contraception.
Micks E; Prager S
Clin Obstet Gynecol; 2014 Dec; 57(4):751-62. PubMed ID: 25254920
[TBL] [Abstract][Full Text] [Related]
2. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
3. Postpartum contraception.
Sober S; Schreiber CA
Clin Obstet Gynecol; 2014 Dec; 57(4):763-76. PubMed ID: 25264698
[TBL] [Abstract][Full Text] [Related]
4. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
5. Increasing LARC utilization: any woman, any place, any time.
Hathaway M; Torres L; Vollett-Krech J; Wohltjen H
Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089
[TBL] [Abstract][Full Text] [Related]
6. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
Rose SB; Garrett SM; Stanley J
Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
[TBL] [Abstract][Full Text] [Related]
7. Effect of previous induced abortions on postabortion contraception selection.
Keene M; Roston A; Keith L; Patel A
Contraception; 2015 May; 91(5):398-402. PubMed ID: 25637863
[TBL] [Abstract][Full Text] [Related]
8. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
Weisberg E; Bateson D; McGeechan K; Mohapatra L
Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):5-14. PubMed ID: 24229367
[TBL] [Abstract][Full Text] [Related]
9. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
10. Attitudes toward long-acting reversible contraception among young women seeking abortion.
Rose SB; Cooper AJ; Baker NK; Lawton B
J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive discontinuation and pregnancy postabortion in Nepal: a longitudinal cohort study.
Puri M; Henderson JT; Harper CC; Blum M; Joshi D; Rocca CH
Contraception; 2015 Apr; 91(4):301-7. PubMed ID: 25553872
[TBL] [Abstract][Full Text] [Related]
12. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC
Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
[TBL] [Abstract][Full Text] [Related]
13. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
14. Introduction of postabortion contraception, prioritizing long-acting reversible contraceptives, in the principal maternity hospital of Gabon.
Mayi-Tsonga S; Obiang PA; Minkobame U; Ngouafo D; Ambounda N; de Souza MH
Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S45-8. PubMed ID: 24745694
[TBL] [Abstract][Full Text] [Related]
15. Contraception following abortion and the treatment of incomplete abortion.
Gemzell-Danielsson K; Kopp Kallner H; Faúndes A
Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S52-5. PubMed ID: 24739476
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study.
Short M; Dallay D; Omokanye S; Stauch K; Inki P
Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):29-38. PubMed ID: 24289528
[TBL] [Abstract][Full Text] [Related]
17. Contraceptive implants.
McDonald-Mosley R; Burke AE
Semin Reprod Med; 2010 Mar; 28(2):110-7. PubMed ID: 20352560
[TBL] [Abstract][Full Text] [Related]
18. Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
Krashin JW; Stuart GS; Garrett J; Spector H; Bryant AG; Charm S; Morse JE
Obstet Gynecol; 2017 Jul; 130(1):109-117. PubMed ID: 28594755
[TBL] [Abstract][Full Text] [Related]
19. Contraceptive development and better family planning.
Segal SJ
Bull N Y Acad Med; 1996; 73(1):92-104. PubMed ID: 8804742
[TBL] [Abstract][Full Text] [Related]
20. Unscheduled vaginal bleeding with progestin-only contraceptive use.
Zigler RE; McNicholas C
Am J Obstet Gynecol; 2017 May; 216(5):443-450. PubMed ID: 27988268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]